News | September 24, 2022
Unichem Laboratories sale its stake in Optimus Drugs
The company has received payment towards completion of sale of the first tranche from Sekhmet Pharmaventures Private Limited.
The company has received payment towards completion of sale of the first tranche from Sekhmet Pharmaventures Private Limited.
The company has developed the API in house at its R&D center in Hyderabad
40,000 visitors and representatives of more than 80 countries set to visit the show
This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades.
The drug is to be supplied in 105 low and middle-income countries and 10 Indian firms are on the list
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
Subscribe To Our Newsletter & Stay Updated
